Navitoclax-piperazine (ABT-263-piperazine) is a drug-linker conjugate used in the synthesis of PROTAC DT2216, which is a degrader of B-cell lymphoma extra large (BCL-XL).

纯度：≥98%

CAS：2143096-93-7